1. Frost HM (1973) Bone remodeling and its relationship to metabolic bone diseases. C.C. Thomas, Springfield, IL
2. Delmas PD, Mann KG, Riggs BL (1983) Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone-Gla protein. Calcif Tissue Int. 35 (Suppl.) A59
3. Beresford JN, Gallagher JA, Poser J, Gowen M, Couch M, Yates AJP, Kanis JA, Russell RGG. (1983) Effects of the anabolic steroid, stanozolol, on human bone cellsin vitro. Calcif. Tissue Int. 35 (Suppl) A25
4. Yates AJP, Series JJ, Galloway J, Couch M, Gallacher JA, Sharrard M, Coulton L, Russell RGG, Kanis JA (1983) Action of stanozolol in osteoporosis. Calcif. Tissue Int. 35 (Suppl) A64
5. Parfitt AM, Duncan H. (1982) Metabolic bone disease affecting the spine.In: Rothman, R., Simeone, F. (eds) The Spine. W. B. Saunders, Philadelphia, 2nd ed